USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

AP System (DiAs or inControl) with USS Virginia

Subject will participate in two 24-hour study insulin pump and AP System training sessions. At the conclusion of each training session, subject will wear the equipment at home for a total of 5 weeks.

DEVICE

Sensor-Augmented Pump Therapy (placebo)

Subject will participate in 5 weeks use of CGM and personal insulin pump at home.

Trial Locations (2)

22903

University of Virginia Center for Diabetes Technology, Charlottesville

94305

Stanford University, Stanford

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Stanford University

OTHER

collaborator

TypeZero Technologies, LLC

INDUSTRY

lead

University of Virginia

OTHER

NCT02302963 - USS Virginia Closed-Loop Versus SAP Therapy for Hypoglycemia Reduction in T1D | Biotech Hunter | Biotech Hunter